We aimed to evaluate and compare the local and systemic cardiovascular effects of urocortins 2 and 3 in patients with heart failure and healthy subjects by assessing (i) local forearm arterial blood flow using venous occlusion plethysmography and (ii) cardiac output and vascular resistance using thoracic bioimpedance cardiography. The gene discussed is UCN2; the disease is heart failure.